Structure of human serum lipoproteins inferred from compositional analysis.
about
Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular diseasePancreatic carboxyl ester lipase: a circulating enzyme that modifies normal and oxidized lipoproteins in vitroNew insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolismStructural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferaseAmyloid protein SAA is associated with high density lipoprotein from human serumA computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolismAn in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathwayPhylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I.Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasoundSelective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique.Cholesterol esterase action on human high density lipoproteins and inhibition studies: detection by MALDI-TOF MS.Model of human low-density lipoprotein and bound receptor based on cryoEMSurface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles.Homeostasis of free cholesterol in the blood: a preliminary evaluation and modeling of its passive transport.Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosisDietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation.Resonance energy transfer from a cylindrical distribution of donors to a plane of acceptors. Location of apo-B100 protein on the human low-density lipoprotein particle.Evidence for a Trypanosoma brucei lipoprotein scavenger receptor.Surface properties of native human plasma lipoproteins and lipoprotein models.Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.In vivo interaction of synthetic acylated apopeptides with high density lipoproteins in rat.Electron microscopy of negatively stained and freeze-etched high density lipoprotein-3 from human serum.Quantification of HDL particle concentration by calibrated ion mobility analysis.Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystalsHigh-density lipoprotein heterogeneity and function in reverse cholesterol transport.Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.Fluorescent low density lipoprotein for observation of dynamics of individual receptor complexes on cultured human fibroblasts.Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetesControl of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complexNear-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.In silico modeling of the dynamics of low density lipoprotein composition via a single plasma sample.A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study.Transport of apolipoproteins A-I and A-II by human thoracic duct lymphEffects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux.Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies.Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol.
P2860
Q24561663-2785C0F4-78D9-4CFB-8497-DF9857005A71Q24562262-19D4B95B-B1C7-41DE-90E6-152A03CE157FQ26851804-075937BA-6AB3-425D-8874-BEF182E0B9DEQ27626928-1BB9C455-AD3C-43DA-8DEF-8B34280F927EQ28263298-16C77013-C22F-4F15-8193-AD7934B8C262Q28538300-D13DA83B-1FB4-437B-952C-53B644C12F67Q28540807-867E8184-DFD5-4DB4-A4C6-39E2A07D7513Q30011366-29AE43C6-BF5D-44C3-A6B5-21926C76721CQ30362081-576FBA40-BAEF-4634-B016-544E62661BB3Q30576734-E254307C-B5B7-4108-AF67-0EED96003384Q31141789-EE50569F-8479-406B-8E17-A93E5977876FQ33560560-B5718BF6-2291-42AC-A51D-9C1AD1561536Q33634176-B4FC2E8A-7EA9-4A96-843E-D0C304B45491Q33653598-0E86F84D-0E02-42B3-9682-375B00EDC63DQ33655596-75E76381-DB89-4F8C-B298-85E7B4774F3CQ33927951-8F4E4635-9822-46D6-9C58-6616C1A810E9Q34126416-99E53D7F-DD10-4801-BA56-57AE779E4A10Q34156389-5CB725C4-E6A1-418A-B451-7408964C1F95Q34179965-8DEAEAE5-A9B6-4598-BCB9-4496392C831DQ34220871-90EF1E21-6039-4897-854D-A2765C9E4D71Q34512603-3D25E21F-D3A5-493F-B041-A9F667BDFA08Q34521392-64942D83-BCD4-4FE4-974A-55F1B565036DQ35061432-27726ADB-FBBE-46A1-A6BC-6536CF49A52CQ35073968-C719BFBE-3237-4CF6-B969-B6C55955E691Q35117457-5D30715B-722F-4AF2-ABD6-6D99DBD5FD25Q35209236-F4F47B99-4E32-484C-827A-A11FA7E47D55Q35546972-FFE13C33-0AF5-44EF-81B7-1EEAD73E3B2CQ35561984-4819BC3E-6269-40E7-98E0-6D1B9C2D14FEQ36205216-09D4A6AD-1FE4-4F0D-8ACD-C27250185224Q36391865-24F439F3-2AA2-4B76-A753-A5E1B053815EQ36500202-0622370E-1D1F-41F4-AD06-1417E03A7FE5Q36727392-930D0CF3-D75D-4729-B214-A666011D3047Q36840545-AD2EF5E3-1CB4-484B-9062-E02AA269E57AQ36843279-D3704299-3B34-4D19-B043-817E55CE73F8Q36892261-02700590-F2C7-472C-8F5E-BC6E99391F15Q36996835-54B9974D-A609-43A0-AB3F-EB936A7D8A8EQ37086142-6119DAC7-5206-40B6-A461-DE13AC7C4167Q37163036-3EA18979-472A-4B9F-A968-59522A51E26BQ37177263-D857E9EA-5FA2-44FB-88C0-043CBD76F11AQ37252792-05DA7D84-F4F6-4FDC-B0B1-568BB4CE8B01
P2860
Structure of human serum lipoproteins inferred from compositional analysis.
description
1977 nî lūn-bûn
@nan
1977 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի մարտին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
name
Structure of human serum lipoproteins inferred from compositional analysis.
@ast
Structure of human serum lipoproteins inferred from compositional analysis.
@en
type
label
Structure of human serum lipoproteins inferred from compositional analysis.
@ast
Structure of human serum lipoproteins inferred from compositional analysis.
@en
prefLabel
Structure of human serum lipoproteins inferred from compositional analysis.
@ast
Structure of human serum lipoproteins inferred from compositional analysis.
@en
P2093
P2860
P356
P1476
Structure of human serum lipoproteins inferred from compositional analysis.
@en
P2093
P2860
P304
P356
10.1073/PNAS.74.3.837
P407
P577
1977-03-01T00:00:00Z